https://cpi-613inhibitor.com/l....sd1-inhibits-aberran
Our study has pinpointed a novel molecular mechanism of breast cancer lung metastasis, attributable to exosome cargo miRNAs, offering a new therapeutic avenue for cancer immunotherapy. Our study has unveiled a novel molecular pathway, mediating breast cancer lung metastasis via exosome-bound microRNAs, and offers a fresh therapeutic approach for cancer immunotherapy. A large global number of women experience the highly malignant condition of breast cancer. Sesamol, a naturally derived